Otolaryngologic manifestations of small vessel vasculitis (Q34977180)

5 August 2017

Otolaryngologic manifestations of small vessel vasculitis (English)

1 reference

5 August 2017

George Metaxaris

1

1 reference

5 August 2017

Emmanuel P Prokopakis

2

1 reference

5 August 2017

Alexander D Karatzanis

3

1 reference

5 August 2017

George Sakelaris

4

1 reference

5 August 2017

Panagiotis Heras

5

1 reference

5 August 2017

George A Velegrakis

6

1 reference

5 August 2017

Emmanuel S Helidonis

7

1 reference

5 August 2017

1 October 2002

1 reference

5 August 2017

4

1 reference

inferred from page(s)

published in

Auris Nasus Larynx

1 reference

5 August 2017

29

1 reference

5 August 2017

4

1 reference

5 August 2017

353-356

1 reference

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

Primary systemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

ANCA and associated diseases: immunodiagnostic and pathogenetic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa Group

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

Use of anticytoplasmic autoantibodies in the diagnosis of Wegener's granulomatosis with subglottic stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

Nasal manifestations of rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

Utility of laboratory testing in autoimmune inner ear disease

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

The American College of Rheumatology 1990 criteria for the classification of churg-strauss syndrome (allergic granulomatosis and angiitis)

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DR beta shared-epitope hypothesis accounts for the disease in only a minority of Greek patients

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

HLA-class II alleles and C4 null genes in Greeks with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

Small-vessel vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

Wegener's granulomatosis of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0385-8146%2802%2900062-7

7 January 2021

10.1016/S0385-8146(02)00062-7

Identifiers

DOI

1 reference

5 August 2017

1 reference